Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N P Verhoeff

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Psychiatry Research|December 1, 1994
Dopamine receptor availability in Tourette's syndromeM S George, M M Robertson, D C Costa, et al.
Nuclear Medicine Communications|November 1, 1996
Potential for imaging cerebral amyloid deposits using 123I-labelled serum amyloid P component and SPETM Bornebroek, J F Verzijlbergen, J Haan, et al.
European Journal of Nuclear Medicine|September 1, 1993
Dosimetry of iodine-123 iodobenzamide in healthy volunteersN P Verhoeff, E B Sokole, M Stabin, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 3, 2001
Serotonin 5-HT1A receptor binding potential declines with age as measured by [11C]WAY-100635 and PETJ Tauscher, N P Verhoeff, B K Christensen, et al.
Synapse (New York, N.Y.)|June 1, 1994
No direct correlation between behaviorally active doses of the dopamine D2 agonist LY 171555 and displacement of [123I]IBZM as measured with SPECT in MPTP monkeysR J Vermeulen, B Drukarch, N P Verhoeff, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 24, 1999
Graphical analysis and simplified quantification of striatal and extrastriatal dopamine D2 receptor binding with [123I]epidepride SPECTM Ichise, M Fujita, J P Seibyl, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 17, 2000
Test-retest reproducibility of extrastriatal dopamine D2 receptor imaging with [123I]epidepride SPECT in humansA Varrone, M Fujita, N P Verhoeff, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1991
In vitro and in vivo D2-dopamine receptor binding with [123I]S(-) iodobenzamide ([123I]IBZM) in rat and human brainN P Verhoeff, M Bobeldijk, M G Feenstra, et al.
Psychological Medicine|May 1, 1994
Stereotypy, schizophrenia and dopamine D2 receptor binding in the basal gangliaB M Pedro, L S Pilowsky, D C Costa, et al.
European Journal of Pharmacology|January 29, 2000
Imaging extrastriatal dopamine D(2) receptor occupancy by endogenous dopamine in healthy humansM Fujita, N P Verhoeff, A Varrone, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Psychiatry Research|December 1, 1994
Dopamine receptor availability in Tourette's syndromeM S George, M M Robertson, D C Costa, et al.
Nuclear Medicine Communications|November 1, 1996
Potential for imaging cerebral amyloid deposits using 123I-labelled serum amyloid P component and SPETM Bornebroek, J F Verzijlbergen, J Haan, et al.
European Journal of Nuclear Medicine|September 1, 1993
Dosimetry of iodine-123 iodobenzamide in healthy volunteersN P Verhoeff, E B Sokole, M Stabin, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 3, 2001
Serotonin 5-HT1A receptor binding potential declines with age as measured by [11C]WAY-100635 and PETJ Tauscher, N P Verhoeff, B K Christensen, et al.
Synapse (New York, N.Y.)|June 1, 1994
No direct correlation between behaviorally active doses of the dopamine D2 agonist LY 171555 and displacement of [123I]IBZM as measured with SPECT in MPTP monkeysR J Vermeulen, B Drukarch, N P Verhoeff, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 24, 1999
Graphical analysis and simplified quantification of striatal and extrastriatal dopamine D2 receptor binding with [123I]epidepride SPECTM Ichise, M Fujita, J P Seibyl, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 17, 2000
Test-retest reproducibility of extrastriatal dopamine D2 receptor imaging with [123I]epidepride SPECT in humansA Varrone, M Fujita, N P Verhoeff, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1991
In vitro and in vivo D2-dopamine receptor binding with [123I]S(-) iodobenzamide ([123I]IBZM) in rat and human brainN P Verhoeff, M Bobeldijk, M G Feenstra, et al.
Psychological Medicine|May 1, 1994
Stereotypy, schizophrenia and dopamine D2 receptor binding in the basal gangliaB M Pedro, L S Pilowsky, D C Costa, et al.
European Journal of Pharmacology|January 29, 2000
Imaging extrastriatal dopamine D(2) receptor occupancy by endogenous dopamine in healthy humansM Fujita, N P Verhoeff, A Varrone, et al.
Pageof 5